The groundbreaking therapy of the medication represents a major breakthrough in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide impacts two pathways – the GLP-1 hormone and GIP – https://tirzepatide-peptide347334.bloggip.com/42531067/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment